Condition-Specific Health
Tegoprubart Islet Transplant Trial Posts Updated T1D Data
Immunosuppression mechanism under scrutiny as transplant tolerance data edges closer to clinical relevance for metaboli…
All 681 stories
Science & Research
Verekitug TSLP Receptor Data to Be Presented at EAACI 2026
Responder analysis from the Phase 2 VIBRANT trial will detail the proportion of CRSwNP patients achieving clinically me…
![[Latest] Surgical Masks Market Size Will Attain USD 6.76 Billion by 2034 Registering a Promising CAGR of 5.5% - Exclusive Report by ZMR | Global Surgical Masks Market Size, Share, Trends Analysis Report](https://functional.news/public/functional/uploads/surgical-masks-market-forecast-has-no-place-in-functional-foods-card.jpg)
Industry & Business
Surgical Masks Market Forecast Has No Place in Functional Foods
Content submitted for republication does not meet editorial criteria for functional ingredients, finished formulations,…
Industry & Business
Editor's Note: This Release Falls Outside Functional News Coverage
Functional News covers ingredients, finished formulations, and regulatory developments in functional foods and nutraceu…
![[Latest] Value Based Healthcare Market Size Will Surpass USD 12.48 Billion by 2034 Growing at 11.75% CAGR - Exclusive Report by ZMR | Global Value Based Healthcare Market Size, Share, Trends Analysis Report](https://functional.news/public/functional/uploads/value-based-care-growth-opens-new-channels-for-functional-foods-card.jpg)
Industry & Business
Value-Based Care Growth Opens New Channels for Functional Foods
An 11.75% CAGR through 2034 signals that payers and providers are increasingly willing to reimburse nutrition-forward i…
Ingredients & Formulation
AlloNK Cell Therapy Earns FDA RMAT Tag for Refractory RA
The RMAT designation accelerates development dialogue with FDA — a regulatory milestone operators in the immunology-adj…
Health & Wellness
Engitix-GSK Collaboration Targets Liver Fibrosis Regression via ECM Platform
The deal signals pharma's growing interest in fibrosis biology that increasingly intersects with hepatoprotective nutra…
Ingredients & Formulation
DR3 Antibody Candidate SL-325 Reports Phase 1 Safety Data
The Austin-based biotech's lead candidate targets the DR3 pathway — a mechanism drawing growing interest in immune-medi…
Science & Research
CAR-T Therapy LYL273 Advances to Phase 1/2 in Colorectal Cancer
The amendment signals regulatory confidence in next-generation cell therapy manufacturing as solid-tumor CAR-T programs…
Functional Foods & Beverages
GEN Restaurant Group Enters Retail with Six-SKU Save Mart Launch
The move signals growing operator interest in CPG adjacency as restaurant brands leverage existing consumer loyalty to …
Condition-Specific Health
FDA Accepts BLA for Vedolizumab Biosimilar AVT16 from Alvotech
The gut-health biologics pipeline inches forward as a vedolizumab biosimilar clears a key regulatory milestone — with i…
Condition-Specific Health
FDA Accepts BLA for AVT16, Vedolizumab Biosimilar Targeting IBD
The gut-targeted integrin inhibitor category draws biosimilar competition as regulators advance interchangeability revi…